TOKYO—Takeda Pharmaceutical Co., which distributes Moderna Inc.’s COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio as shots for dengue fever and COVID-19 near regulatory approval, its chief executive said. Takeda, Japan’s biggest drugmaker and among the top 10 globally after its 2019 takeover of Shire Plc, has traditionally been…